Evaluating non-invasive methods for diagnosing portal hypertension
Official title: Noninvasive Tools for the Diagnosis of Porto-sinusoidal Vascular Disease: a Single-center, Prospective, Cohort Study
Run by Nanfang Hospital, Southern Medical University · NCT06500403 · Data updated 2026-11-12
This study is testing if measuring the stiffness of the liver and spleen can help diagnose portal hypertension in patients who have had chemotherapy, instead of using more invasive methods like liver biopsies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Nanfang Hospital, Southern Medical University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | February 28, 2024 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | July 15, 2024 |
| Trial ID | NCT06500403 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-80 who have received platinum-based chemotherapy for organ tumors.
✕Probably not a fit
Patients with liver cirrhosis, those who have undergone liver transplantation, or individuals with severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the effectiveness of measuring liver and spleen stiffness as non-invasive diagnostic tools for Porto-Sinusoidal Vascular Diseases (PSVD) in patients who have undergone platinum-based chemotherapy. The study will involve a single-center, prospective approach to gather data on the correlation between stiffness measurements and the diagnosis of PSVD, traditionally reliant on invasive liver biopsies. Additionally, the research seeks to identify potential biomarkers that could enhance the diagnostic process for PSVD.
Why it matters
Potential benefit: If successful, this study could provide a less invasive and more accurate method for diagnosing PSVD, improving patient care.
How similar studies have gone: Previous studies have indicated that liver and spleen stiffness measurements can accurately diagnose and predict outcomes for similar conditions, suggesting a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Received platinum chemotherapy for organ tumors; 2. Ages 18-80; 3. sign the informed consent voluntarily. Exclusion Criteria: 1. Liver pathology suggested cirrhosis; 2. Underwent liver transplantation; 3. Combined with hepatocellular carcinoma exceeding Milan criteria; 4. Complicated with severe heart, kidney, or lung failure; 5. Pregnant or lactating women; 6. Data is seriously missing; 7. Patients were judged not suitable for participation in this study by the researchers.
Where it's running
-
Nanfang hospital, Southern Medical Uiversity
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Xiaofeng Zhang — Nanfang Hospital, Southern Medical University
- Study coordinator: Xiaofeng Zhang
- Email: 1282614092@qq.com
- Phone: +8618565552050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing HVPG and endoscopic ultrasound portal pressure measurements
This study will test whether an endoscopic ultrasound method (EUS-PPG) gives the same portal pressure readings as the standard hepatic venous pressure gradient (HVPG) in adults who need portal pressure measurement.
-
Registry for patients undergoing TIPS implantation for portal hypertension
This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.
-
Predicting liver failure after surgery in patients with chronic liver disease
This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.